Anti-UGT1A5 monoclonal antibody

Pre-made anti-UGT1A5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to UGT1A5/UGT1A5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2227-Ab-1/ GM-Tg-hg-IP2227-Ab-2Anti-Human UGT1A5 monoclonal antibodyHuman
GM-Tg-rg-IP2227-Ab-1/ GM-Tg-rg-IP2227-Ab-2Anti-Rat UGT1A5 monoclonal antibodyRat
GM-Tg-mg-IP2227-Ab-1/ GM-Tg-mg-IP2227-Ab-2Anti-Mouse UGT1A5 monoclonal antibodyMouse
GM-Tg-cynog-IP2227-Ab-1/ GM-Tg-cynog-IP2227-Ab-2Anti-Cynomolgus/ Rhesus macaque UGT1A5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2227-Ab-1/ GM-Tg-felg-IP2227-Ab-2Anti-Feline UGT1A5 monoclonal antibodyFeline
GM-Tg-cang-IP2227-Ab-1/ GM-Tg-cang-IP2227-Ab-2Anti-Canine UGT1A5 monoclonal antibodyCanine
GM-Tg-bovg-IP2227-Ab-1/ GM-Tg-bovg-IP2227-Ab-2Anti-Bovine UGT1A5 monoclonal antibodyBovine
GM-Tg-equg-IP2227-Ab-1/ GM-Tg-equg-IP2227-Ab-2Anti-Equine UGT1A5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2227-Ab-1/ GM-Tg-hg-IP2227-Ab-2; GM-Tg-rg-IP2227-Ab-1/ GM-Tg-rg-IP2227-Ab-2;
GM-Tg-mg-IP2227-Ab-1/ GM-Tg-mg-IP2227-Ab-2; GM-Tg-cynog-IP2227-Ab-1/ GM-Tg-cynog-IP2227-Ab-2;
GM-Tg-felg-IP2227-Ab-1/ GM-Tg-felg-IP2227-Ab-2; GM-Tg-cang-IP2227-Ab-1/ GM-Tg-cang-IP2227-Ab-2;
GM-Tg-bovg-IP2227-Ab-1/ GM-Tg-bovg-IP2227-Ab-2; GM-Tg-equg-IP2227-Ab-1/ GM-Tg-equg-IP2227-Ab-2
Products NameAnti-UGT1A5 monoclonal antibody
Formatmab
Target NameUGT1A5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-UGT1A5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2227-Ag-1Recombinant multi-species UD15/ UGT1A5/ UDPGT protein


    Target information

    Target IDGM-IP2227
    Target NameUGT1A5
    Gene ID54579
    Gene Symbol and SynonymsUDPGT,UDPGT 1-5,UGT1A5,UGT1E
    Uniprot AccessionP35504
    Uniprot Entry NameUD15_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000288705
    Target ClassificationN/A

    The target: UGT1A5, gene name: UGT1A5, also named as UDPGT, UDPGT 1-5, UGT1E. This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.